Current pharmaceutical biotechnology
Enhancement of Fowlicidin-1's Therapeutic Efficacy: Mitigation of Toxicity via a Chitosan Cross-Linked Nanocarrier System.
Ammar Almaaytah, Bayan Bataineh, Nizar M Mhaidat, Salsabeel Sabi
Published: 202510.2174/0113892010389986251016043606
Abstract
INTRODUCTION: The rise of antimicrobial resistance, coupled with the declining discovery of new antibiotics, has intensified the need for alternative therapeutics. Antimicrobial peptides (AMPs), such as Fowlicidin-1, offer broad-spectrum antimicrobia…
Preview only. Read the full abstract at the source